Influence of CD40 ligation on survival and apoptosis of B-CLL cells in vitro

Leukemia Research

Volumn 27, Issue 10, 2003, Pages 951-956

  Grdisa, Mira ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Apoptosis; B CLL; CD40L; IL 4; Proliferation

Indexed keywords

CD40 LIGAND; CELL CYCLE PROTEIN; CYCLIN D3; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; FLUDARABINE; INTERLEUKIN 4; PROTEIN P27; REGULATOR PROTEIN;

APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CANCER CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 0038353364     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(03)00028-6     Document Type: Article

References (40)

1. Kipps TJ. Chronic lymphocytic leukemia and related diseases. In: Beutler E, Lichtman EA, Coller BS, Kipps TJ, editors. Williams hematology. New York: McGrw-Hill; 1995. p. 1017.
2. Caligaris-Cappio F. B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. Blood. 87:1996;2615-2620.
3. Reed J.C. Molecular biology of chronic lymphocytic leukemia: implications for therapy. Semin. Hematol. 35:1998;3-13.
4. Kip1 in chronic B-cell lymphocytic leukemia. Blood. 91:1998;4694-4700.
5. Ranheim E.A., Kipps T.J. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:1993;925-935.
6. Ranheim E.A., Cantwell M.J., Kipps T.J. Expression of CD27 and its ligand CD70 on chronic lymphocytic leukemia B cells. Blood. 85:1995;3556-3565.
7. Ranheim E., Kipps T.J. Tumor necrosis factor-alfa facilates induction of CD80 (B7-1) and CD54 on human B cells by activated T-cells: complex regulation by IL-4, IL-10, and CD40L. Cell Immunol. 161:1995;226-235.
8. Schultze J., Nadler L.M., Gribben J.G. B7-mediated costimulation and the immune response. Blood Rev. 10:1996;111-127.
9. Boussiotis V.A., Freeman G.J., Gribben J.G., Nadler L.M. The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunol. Rev. 153:1996;5-26.
10. Schwartz R.H. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell. 71:1992;1065-1068.
11. Schultze J.L., Cardoso A.A., Freeman G.J., Seamon M.J., Daley J., Pinkus G.S.et al. Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity. PNAS USA. 92:1995;8200-8204.
12. Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.P., van Kooten C.et al. The CD40 antigen and its ligand. Ann. Rev. Immunol. 12:1994;881-922.
13. Armitage R.J., Fanslow W.C., Strockbine L., Sato T.A., Clifford K.N., Macduff B.M.et al. Molecular and biological characterization of a murine ligand for CD40. Nature. 357:1992;80-82.
14. Noelle R.J., Ledbetter J.A., Aruffo A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol. Today. 13:1992;431-433.
15. Clark E.A., Ledbetter J.A. How B and T cells talk to each other. Nature. 367:1994;425-428.
16. Durie F.H., Foy T.M., Masters S.R., Laman J.D., Noelle R.J. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today. 15:1994;406-411.
17. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47:1987;936-942.
18. Kato K., Cantwell M., Sharma S., Kipps T.J. Gene transfer of CD40-ligand induces autologus immune recognition of chronic lymphocytic leukemia B cells. J. Clin. Invest. 101:1998;1133-1141.
19. Banchereau J., Blanchard D., Briere F., Galizzi J.P., Garrone P., Hermann P.et al. Role of cytokines in human B lymphocyte growth and differentiation. Nouv. Rev. Franc. d'Hematol. 35:1993;61-63.
20. Sherr C.J. Mammalian G1 cyclins. Cell. 73:1993;1059-1065.
21. Wagner E.F., Hleb M., Hanna N., Sharma S. A pivotal role of cyclin D3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2, IL-4, or IL-10-mediated human B cell proliferation. J. Immunol. 161:1998;1123-1131.
22. Kip1. J. Clin. Invest. 103:1999;597-604.
23. Kip1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell. 69:1994;597-604.
24. Mai A., Poon R.Y.C., Howe P.H., Toyoshima H., Hunter T., Harter L.M. Nature. 380:1996;262-265.
25. Ewen M. The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev. 13:1994;45-51.
26. Buhmann R., Nolte A., Westhaus D., Emmerich B., Hallek M. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogenic versus autologous T cells generates different types of effector cells. Blood. 93:1999;1992-2002.
27. Crawford D.H., Catovsky D. In vitro activation of leukemic B cells by interleukin-4 and antibodies to CD40. Immunology. 80:1993;40-44.
28. Fluckiger A.C., Rossi J.F., Bussel A., Bryon P., Banchereau J., Defrance T. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood. 80:1992;3173-3182.
29. Vandenhove L.E., Vangool S.W., Vandenberghe P., Bakkus M., Thielemans K., Boogaerts M.A.et al. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules. Leukemia. 11:1997;572-580.
30. Cantwell M.J., Hua T., Pappas J., Kipps T.J. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Nat. Med. 3:1997;984-989.
31. Jaiswal A.I., Dubey C., Swain S.L., Croft M. Regulation of CD40 ligand expression on nad've CD4 T cells: a role for TCR but not co-stimulatory signals. Int. Immunol. 8:1996;275-285.
32. Jaiswal A.I., Croft M. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response. J. Immunol. 159:1997;2282-2291.
33. Chu P., Deforce D., Pederson I.M., Kim Y., Kitada S., Reed J.C.et al. Latent sensitivity to fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia. PNAS USA. 99:2002;3854-3859.
34. Klein A., Miera O., Bauer O., Glofier S., Schriever F.et al. Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair. Leukemia. 14:2000;40-46.
35. Jacob A., Pound J.D., Challa A., Gordon J. Release of clonal block in B cell chronic lymphocytic leukemia by engagement of co-operative epitopes on CD40. Leuk. Res. 22:1998;379-382.
36. Romano F.M., Lamberti A., Tassone P., Alfinito F., Costantini S., Chiurazzi F.et al. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. Blood. 92:1998;990-995.
37. Kitada S., Zapata J.M., Andreeff M., Reed J.C. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukemia. Br. J. Haematol. 106:1999;995-1004.
38. Furman R.R., Asgary Z., Mascarenhas J.O., Liou H.C., Schattee E.J. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells. J. Immunol. 164:2000;2200-2206.
39. Schattner E.J. CD40 ligand in CLL pathogenesis and therapy. Leuk. Lymphoma. 37:2000;461-472.
40. Granziero L., Ghia P., Circosta P., Gottardi D., Strola G., Geuna M.et al. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood. 97:2001;2777-2783.